Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
Explore this paper's citation graph
Summary
An important consideration is the need for simplicity in any risk-stratification scheme and to have a risk score that at least can be used in everyday clinical practice, applicable to the majority of AF patients.
- Type
- letter
- Published
- 2011-02-01
- Cited by
- 30
- References
- 22
- Access
- Open access
- OpenAlex
- https://openalex.org/W2077899415
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:205054212
Keywords
Medicine, Atrial fibrillation, Stroke (engine), Internal medicine, Cardiology
References
- New oral anticoagulant drugs in cardiovascular disease
- Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
- AL cardiac amyloidosis and arterial thromboembolic events
- Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
- EFFECT OF AGE AND RENAL FUNCTION ON THE RISKS OF STROKE AND MAJOR BLEEDING WITH DABIGATRAN COMPARED TO WARFARIN: AN ANALYSIS FROM THE RE-LY STUDY
- Low glomerular filtration rate and risk of stroke: meta-analysis
- Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
- Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
- Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy.
- Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: the ATRIA Study
- Dabigatran versus warfarin in patients with atrial fibrillation.
- Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
- Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
- Dilemmas in the management of atrial fibrillation in chronic kidney disease.
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review
- Independent predictors of stroke in patients with atrial fibrillation
Cited by
- Patientenauswahl für die Implantation eines Vorhofohr-Okkluders in der Primär- und Sekundärprävention des kardioembolischen Schlaganfalls bei Vorhofflimmern
- Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke.
- Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
- Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
- New Oral Anticoagulants
- Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
- To the Editor - Adding renal dysfunction to CHA₂DS₂-VASc improves stroke prediction postcatheter ablation.
- Renal dysfunction and long-term risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting.
- Comment évaluer le risque ischémique et hémorragique cérébral dans la fibrillation atriale ? Place des approches morphologiques et biologiques
- Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
- Risk of Thromboembolic Events in Atrial Fibrillation With Chronic Kidney Disease
- Renal Dysfunction, Stroke Risk Scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the Risk of Thromboembolic Events After Catheter Ablation of Atrial Fibrillation: The Leipzig Heart Center AF Ablation Registry
- Practical Management of Stroke Prevention in Patients with Atrial Fibrillation and Renal Impairment Receiving Newer Oral Anticoagulants: Focus on Rivaroxaban
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
- Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
- Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study.
- "R" for "renal" and for "risk": refining risk stratification for stroke in atrial fibrillation.
- Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
- Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk.
- Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
Related papers
- Drug Interactions and Risk of Bleeding among Patients with Atrial Fibrillation (AF) Discharged with Warfarin
- Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011
- Streptokinase increased mortality in acute ischemic stroke
- Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.
- Changes in the CHA2DS2-VASC score as a predictor of incident atrial fibrillation in older Chinese individuals: the AF-CATCH study
- Comparison of CHA2DS2-VASc and C2HEST scores for predicting the incidence of atrial fibrillation among patients with end-stage renal disease
- Unequal prescription of anticoagulants among females and males with atrial fibrillation and similar stroke risk - should we omit sex category from the CHA2DS2-VASc score?
- Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients.
- CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry
- Abstract 12125: The CHARGE-AF Risk Score Performs Better at Predicting Risk of Atrial Fibrillation than the CHA2DS2-VASc Risk Score in the Framingham Heart Study